"10.1371_journal.pone.0037401","plos one","2012-05-24T00:00:00Z","Helge R√∏sj√∏; Mats Stridsberg; Geir Florholmen; K√•re-Olav Stensl√∏kken; Anett Helleb√∏ Ottesen; Ivar Sjaastad; Cathrine Husberg; Mai Britt Dahl; Erik √òie; William E Louch; Torbj√∏rn Omland; Geir Christensen","Division of Medicine, Akershus University Hospital, L√∏renskog, Norway; Center for Heart Failure Research and K.G. Jebsen Cardiac Research Centre, Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Medical Sciences, Uppsala University, Uppsala, Sweden; Institute for Experimental Medical Research, Oslo University Hospital, Ullev√•l, Oslo, Norway; Department of Molecular Biosciences, University of Oslo, Oslo, Norway; Department of Clinical Molecular Biology, Akershus University Hospital, L√∏renskog, Norway; Research Institute for Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway","Conceived and designed the experiments: HR TO GC. Performed the experiments: HR MS GF KOS AHO IS CH MBD E√∏ WEL. Analyzed the data: HR MS GF KOS AHO IS CH MBD E√∏ WEL TO GC. Wrote the paper: HR TO GC.","H.R., M.S., T.O., and G.C. are partners in a patent application filed by the University of Oslo regarding the use of SgII as a cardiac biomarker. There are no other patents, products in development or marketed products to declare. This does not alter the authors‚Äô adherence to all the PLoS ONE policies on sharing data and materials.","2012","05","Helge R√∏sj√∏","HR√√",12,TRUE,3,10,12,3,TRUE,TRUE,TRUE,1,"9",FALSE
